Filing Details

Accession Number:
0001104659-23-129186
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-26 16:05:25
Reporting Period:
2023-12-21
Accepted Time:
2023-12-26 16:05:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1130166 Cyclacel Pharmaceuticals Inc. CYCC Pharmaceutical Preparations (2834) 911766850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1357397 Paul Mcbarron C/O Cyclacel Pharmaceuticals, Inc.,
200 Connell Drive, Suite 1500
Berkeley Heights NJ 07922
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-21 1,886 $3.32 33,378 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants (right to buy) Acquisiton 2023-12-21 1,886 $0.00 1,886 $3.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,886 2023-12-21 2030-12-21 No 4 P Direct
Footnotes
  1. The Reporting Person purchased unregistered shares of the Issuer's common stock in a private placement, pursuant to a Securities Purchase Agreement between the Reporting Person and the Issuer.
  2. Each share of common stock was purchased with an accompanying warrant at an aggregate purchase price of $3.315 per share and accompanying warrant.